INSIGHTS ON DRUG DEVELOPMENT

• Spray Dried Biologics For Pulmonary Dosage Forms

  View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.

• Together, Let's Sail Toward Success

  Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.

• Mammalian Expression

  See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges. 

• A Novel Patient-Derived Colorectal Cancer Organoid Platform

  Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.

• Asymchem's World-Class TIDES Hub: Scaling Innovations For The Future

  3/11/2026

  A tech‑driven, integrated ecosystem strengthens TIDES development and scale‑up, enabling reliable progression from early molecular design to commercial delivery as pipelines grow more complex.

• 3 Key Considerations In Gene Therapy Manufacturing

  7/15/2025

  Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.

• Method Development For Forced Degradation Of GLP-1 Agonist

  3/18/2026

  Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.

• Expanding Opportunities For Inhaled Drug Delivery

  7/11/2025

  Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.

• How Adept Formulation Helps Overcome Manufacturability Challenges

  6/17/2026

  Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.